ID:2028 PLASMA LEVELS OF MMPs AND TIMP-1 IN BLADDER CANCER PATIENTS

Biomedical Research and Therapy - Viet Nam
doi 10.15419/bmrat.v4is.269
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Biomedical Research and Therapy

Related search

Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MMPs Genetic Polymorphisms and Plasma Levels in Hypertensive Disorders of Pregnancy

Journal of Human Hypertension
Internal Medicine
2012English

Plasma Levels of TIMP-1 Are Higher in 34-Year-Old Individuals With Severe 1-Antitrypsin Deficiency

Thorax
PulmonaryRespiratory Medicine
2010English

TIMP-1 and VEGF-165 Serum Concentration During First-Line Therapy of Ovarian Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

TIMP-1 Expression in Human Colorectal Cancer Is Associated With SMAD3 Gene Expression Levels: A Pilot Study

Journal of Gastrointestinal and Liver Diseases
MedicineGastroenterology
2014English

Plasma MMP-2 AND MMP-9 and Their Inhibitors TIMP-1 and TIMP-2 During Human Orthotopic Liver Transplantation

Thrombosis and Haemostasis
Hematology
2004English

Low Levels of Plasma Endothelin-1 in Patients With Retinitis Pigmentosa

Clinical Ophthalmology
Ophthalmology
2010English

Plasma Levels of Nesfatin-1 in Patients With Polycystic Ovary Syndrome

Endocrine Abstracts
2014English

Optimized Targeted Sequencing of Cell-Free Plasma DNA From Bladder Cancer Patients

Scientific Reports
Multidisciplinary
2018English

Polymorphisms and Plasma Levels of IL-27: Impact on Genetic Susceptibility and Clinical Outcome of Bladder Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy